Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHIFENG GOLD
06693
5
CHINAGOLDINTL
02099
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 46.67%4.46B | 56.32%18.06B | 53.73%12.43B | 50.69%6.97B | 53.50%3.04B | 37.12%11.55B | 26.64%8.09B | 34.24%4.63B | 13.94%1.98B | 6.82%8.42B |
| Operating income | 46.67%4.46B | 56.32%18.06B | 53.73%12.43B | 50.69%6.97B | 53.50%3.04B | 37.12%11.55B | 26.64%8.09B | 34.24%4.63B | 13.94%1.98B | 6.82%8.42B |
| Cost of sales | ---- | -49.18%-10.49B | ---- | -47.99%-3.92B | ---- | -39.09%-7.03B | ---- | -26.07%-2.65B | ---- | 3.37%-5.05B |
| Operating expenses | -50.21%-2.27B | -49.18%-10.49B | -65.88%-7.4B | -47.99%-3.92B | -31.67%-1.51B | -39.09%-7.03B | -14.19%-4.46B | -26.07%-2.65B | -0.23%-1.15B | 3.37%-5.05B |
| Gross profit | 43.17%2.19B | 67.41%7.57B | 38.76%5.03B | 54.31%3.05B | 83.54%1.53B | 34.17%4.52B | 46.28%3.62B | 47.03%1.98B | 40.34%834.03M | 26.90%3.37B |
| Selling expenses | -8.41%-6.74M | -28.97%-62.51M | -3.64%-22.43M | -59.16%-25.62M | -6.48%-6.22M | -54.36%-48.47M | 8.37%-21.64M | -5.55%-16.09M | 26.36%-5.84M | 5.21%-31.4M |
| Administrative expenses | 1.64%-320.6M | -11.58%-1.64B | -10.92%-853.32M | -12.45%-699.94M | -29.52%-325.93M | -13.17%-1.47B | -12.30%-769.35M | -8.89%-622.46M | -8.44%-251.65M | 0.32%-1.3B |
| Research and development expenses | -140.39%-91.12M | ---- | -8.45%-214.36M | ---- | 38.18%-37.91M | ---- | 7.79%-197.66M | ---- | -33.52%-61.32M | ---- |
| Profit from asset sales | -6,567.67%-418.86K | ---- | -120.24%-6.9K | ---- | ---6.28K | ---- | -27.43%34.12K | ---- | ---- | ---- |
| Revaluation surplus | 3,519.45%297.09M | ---- | 9,435.64%872.43M | ---- | -72.58%8.21M | ---- | 104.22%9.15M | ---- | 258.76%29.93M | ---- |
| -Changes in the fair value of other assets | 3,519.45%297.09M | ---- | 9,435.64%872.43M | ---- | -72.58%8.21M | ---- | 104.22%9.15M | ---- | 258.76%29.93M | ---- |
| Impairment and provision | -233.03%-6.32M | -240.86%-66.5M | -66.83%-716.93M | -53.10%-17.54M | 38.39%4.75M | 87.09%-19.51M | -410.76%-429.73M | 64.25%-11.46M | -69.87%3.43M | -47.77%-151.06M |
| -Other impairment is provision | -233.03%-6.32M | -240.86%-66.5M | -66.83%-716.93M | -53.10%-17.54M | 38.39%4.75M | 87.09%-19.51M | -410.76%-429.73M | 64.25%-11.46M | -69.87%3.43M | -47.77%-151.06M |
| Special items of operating profit | 210.53%49.94M | 216.86%253.69M | 239.11%161.05M | 262.07%183.1M | 187.78%16.08M | -42.32%-217.09M | 4.43%47.49M | -428.70%-112.98M | -252.68%-18.32M | -351.42%-152.53M |
| Operating profit | 84.39%1.99B | 118.97%6.05B | 94.12%3.88B | 105.19%2.49B | 130.93%1.08B | 59.43%2.76B | 79.56%2B | 59.72%1.21B | 73.65%468.47M | 35.95%1.73B |
| Financing cost | ---- | 7.81%-502.05M | ---- | 4.36%-252.69M | ---- | 10.38%-544.59M | ---- | 15.11%-264.21M | ---- | -13.97%-607.69M |
| Share of profits of associates | ---- | 76.07%20.57M | ---- | 183.88%11.67M | ---- | 1,068.00%11.68M | ---- | 73.21%4.11M | ---- | 139.48%1M |
| Share of profit from joint venture company | ---- | ---- | ---- | 25.31%-357K | ---- | ---1.49M | ---- | ---478K | ---- | ---- |
| Special items of earning before tax | 20.16%-11.14M | ---- | 52.19%-32.2M | ---- | 17.48%-13.95M | ---- | -161.05%-67.36M | ---- | -3,542.43%-16.91M | ---- |
| Earning before tax | 90.82%1.89B | 149.87%5.57B | 124.38%3.57B | 135.96%2.25B | 175.61%989.26M | 97.86%2.23B | 108.07%1.59B | 111.34%953.08M | 128.46%358.93M | 52.40%1.13B |
| Tax | ---- | -199.16%-1.13B | ---- | -108.32%-472.18M | ---- | -31.05%-377.56M | ---- | -164.74%-226.66M | ---- | -60.94%-288.11M |
| After-tax profit from continuing operations | 82.64%1.52B | 139.81%4.44B | 126.59%2.78B | 144.58%1.78B | 197.88%830.19M | 120.81%1.85B | 128.39%1.23B | 98.82%726.42M | 156.11%278.7M | 49.67%838.42M |
| Earning after tax | 82.64%1.52B | 139.81%4.44B | 126.59%2.78B | 144.58%1.78B | 197.88%830.19M | 120.81%1.85B | 128.39%1.23B | 98.82%726.42M | 156.11%278.7M | 49.67%838.42M |
| Minority profit | 91.13%326.86M | 106.16%825.76M | 91.60%667.34M | 94.10%337M | 198.35%171.01M | 163.53%400.53M | 101.58%348.29M | 54.33%173.63M | 466.16%57.32M | -3.95%151.99M |
| Profit attributable to shareholders | 80.44%1.19B | 149.10%3.61B | 140.43%2.12B | 160.44%1.44B | 197.76%659.18M | 111.35%1.45B | 141.07%880.64M | 118.62%552.79M | 124.30%221.38M | 70.77%686.43M |
| Basic earnings per share | 88.24%0.32 | 174.29%0.96 | 111.54%0.55 | 216.67%0.38 | 240.00%0.17 | 150.00%0.35 | 136.36%0.26 | 200.00%0.12 | 66.67%0.05 | 100.00%0.14 |
| Diluted earnings per share | 174.29%0.96 | 216.67%0.38 | 150.00%0.35 | 200.00%0.12 | 100.00%0.14 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.